~~<i id='65EC91E256'><strike id='65EC91E256'><tt id='65EC91E256'><pre id='65EC91E256'></pre></tt></strike></i>~~

Home» comprehensive» leisure time

leisure time

author：explore 2025-10-08 16:19:29 Page View：6

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biotech execs pursue obesity drug boom: ‘It’s the early innings’
Next article： Anesthesiologist group: stop taking Ozempic before surgery

knowledge

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

1:03U.S.Marineswiththe26thMarineExpeditionaryUnitMaritimeSpecialPurposeForce,preparetodeparttheUSSBa

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

AttendeesoftheWorldScoutJamboreepreparetoleaveascoutcampingsiteinBuan,SouthKorea,Tuesday,Aug.8,2023.